Cardiff Oncology, Inc. (CRDF)

NCM – Real Time Price. Currency in USD

1.02

-0.03 (-2.86%)

Market open: Aug 12, 2026, 2:52 PM EDT

0.97

-0.08 (-7.60%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

11.08.2026

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

Positive Phase 2 CRDF-004 data presented in an oral session at ASCO support advancement of 30 mg onvansertib plus FOLFIRI/bevacizumab into planned registrational program for first-line RAS-mutated mCRC

Videos

No Data

There is no data to display

Press releases

11.08.2026

Cardiff Oncology, Inc. (CRDF)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

Videos

No Data

Press releases

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

Videos

No Data

Press releases

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

Search stocks

Cardiff Oncology, Inc. (CRDF)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

Videos

No Data

Press releases

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

Videos

No Data

Press releases

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update